Latest Breaking News On - Biopharmaceuticals inc - Page 5 : comparemela.com

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates NGM, AA, HRT, KNTE

/PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws.

Daniel sadehZachary halperStone point capitalHoldings corporationHalper sadehBiopharma incBiopharmaceuticals incAlumina limitedColumn groupPrnewswire halper sadehGeneral atlanticHalper sadeh llp

SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates NGM, AA, HRT, KNTE -February 26, 2024 at 10:16 pm EST

NEW YORK, Feb. 26, 2024 /PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or.

Zachary halperDaniel sadehBiopharmaceuticals incAlumina limitedPrnewswire halper sadehBiopharma incStone point capitalHalper sadehColumn groupHoldings corporationGeneral atlantic

NGM Biopharmaceuticals (NGM) Neutral Rating Reaffirmed at Citigroup

NGM Biopharmaceuticals (NGM) Neutral Rating Reaffirmed at Citigroup
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Hong kongPrelude capital managementBiopharmaceuticals company profileBiopharmaceuticals incRoyal bankHong kong ltdTower research capitalGet free reportTrading downKong ltdResearch capital

NGM BIOPHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of NGM Biopharmaceuticals, Inc - NGM -February 27, 2024 at 04:11 pm EST

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC are investigating the proposed sale of NGM Biopharmaceuticals, Inc. to affiliates of The.

United statesCharlesc foti jrLewiss kahnColumn groupKahn swick fotiBiopharmaceuticals incFormer attorney generalLouisiana charlesKahn swickPartner lewisFormer louisiana attorney general

Pale Fire Capital SE Acquires New Position in NGM Biopharmaceuticals, Inc (NASDAQ:NGM)

Pale Fire Capital SE bought a new stake in NGM Biopharmaceuticals, Inc. (NASDAQ:NGM – Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 33,800 shares of the company’s stock, valued at approximately $36,000. Several other hedge funds and […]

Blackrock incBiopharmaceuticals incVanguard group incExchange commissionAcadian asset managementPale fire capitalFree reportAsset managementState street corpStreet corpVisit holdingschannelNgm biopharmaceuticalsNasdaq ngmSec filingsHedge fund holdingsInstitutional investor holdings